Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $25,379 - $29,959
-342 Reduced 87.92%
47 $3,000
Q4 2017

Feb 14, 2018

SELL
$81.94 - $87.89 $2,458 - $2,636
-30 Reduced 7.16%
389 $32,000
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $32,292 - $35,841
419
419 $35,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $735B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.